P rogramm - DGU-Kongress

Auszeichnungen 2013
EhrEnmitgliEDschAft WilliAm J. cAtAlonA, m.D.
224
Prof. Catalona
Die Deutsche Gesellschaft für Urologie
e. V. verleiht in diesem Jahr die
Ehrenmitgliedschaft an Herrn Prof.
William J. Catalona in Anerkennung
seiner Verdienste auf dem Gebiet der
Urologie und für die Deutsche Gesellschaft
für Urologie e. V.
Lebenslauf
William J Catalona, M.D., Professor of Urology is the Director of
the Clinical Prostate Cancer Program for the Northwestern University
School of Medicine. A graduate of Yale Medical School,
Dr. Catalona trained in surgery at the Yale New-Haven Hospital,
the University of California San Francisco, and the National Cancer
Institute and trained in urology at the Johns Hopkins Hospital.
He was the first to show that the prostate-specific antigen
(PSA) blood test could be used as a first-line screening test for
prostate cancer and has led the multi-institutional studies for
FDA approval of the free PSA test and the Prostate Health Index
(PHI). He is currently conducting research in prostate cancer
tumor markers and the genetics of prostate cancer. He is an
expert in performing the “nerve-sparing “radical prostatectomy,
having performed more than 6,000 of these operations. He has
received the James Ewing Society Award for Cancer Research,
1972; the American Urological Association’s Gold Cystoscope
Award, 1986, Hugh Hampton Young Award, 1994, and Eugene
Fuller Triennial Prostate Medal, 1998; The Johns Hopkins Society
of Scholars, 1994; the American Association of Genitourinary
Surgeons, James Stockwell Barringer Medal,1999 and Edward
L. Keyes Medal, 2003; Prostate Cancer Foundation, Donald S.
Coffey Physician-Scientist Award, 2005; Florida Prostate Cancer
Network’s, General Schwarzkopf Pioneer in Prostate Cancer
Award, 2005; the Society of Urologic Oncology, Charles Huggins
Medal, 2005, a National Prostate Cancer Coalition’s Golden
Glove Award, 2006, the New York Academy of Medicine’s Ferdinand
Valentine Medal, 2007, and gave the Ramon Guiteras Lecture
at the American Urological Association’s 2011 meeting. He
served as President of the Society of Urologic Oncology and of
The Clinical Society of Genitourinary Surgeons (2011), a society
of academic urologic surgeons founded in 1921. He has served
on advisory boards of the American Cancer Society and the editorial
boards of several medical journals. He has been principal
investigator on grants from the NIH, Department of Defense,
American Cancer Society, and Prostate Cancer Foundation (formerly
CaP CURE). He is currently Principal Investigator on the
Northwestern University Specialized Program of Research Excellence
(SPORE) in Prostate Cancer and Co-Chair of the Inter-
Prostate SPORE Genetics Working Group, Principal Investigator
of the Northwestern branch of the International Consortium of
Prostate Cancer Genetics (ICPCG), collaborating investigator
with the Northwestern Nanotechnology grant, and consultant
and collaborating investigator for Beckman Coulter, Incorporated,
OHMX Corporation, and deCODE genetics, Inc. He is author
of more than 450 articles and books.